Rich People Are Getting Dead People’s Fat Injected Into Their Lips and Butts

It’s such a spot-on allegory for the problems of the modern world that it feels almost too on the nose. A little too perfect. A little overwrought. But, if a fascinating yet disturbing feature from Business Insider is to be believed, then rich people are using parts stripped off of dead people to make themselves […]

What Is the Hims Weight Loss Treatment Plan All About?

Weight loss advice on the internet has become a two-option menu: obsess over food or inject yourself. Scroll long enough and you’ll find both from the same influencer. Somewhere in between is the actual reality of what it means to try to lose weight in 2026, which is mostly just trying to function in a […]

Compounding pharmacy sues Eli Lilly, Novo Nordisk over GLP-1 access

Strive Compounding Pharmacy filed a federal antitrust lawsuit Jan. 14 against Eli Lilly and Novo Nordisk, alleging the two drugmakers used their market power to restrict access to compounded GLP-1 medications and suppress competition. The lawsuit, filed in the U.S. District Court for the Western District of Texas, claims the companies coordinated a campaign to […]

How Will Mounjaro and Zepbound Sales Aid LLY’s Upcoming Q4 Results?

Eli Lilly LLY has emerged as a dominant force in the cardiometabolic market, driven by strong demand for its blockbuster GLP-1 therapies, Mounjaro for type II diabetes (T2D) and Zepbound for obesity. Although both drugs have been on the market for just over three years, they have become LLY’s key top-line drivers. In the first nine […]

Your gym membership just got competition — weight-loss drug Wegovy launches in Malaysia

KUALA LUMPUR, Jan 15 — Novo Nordisk today announced that its weight-loss drug, Wegovy (semaglutide 2.4mg), is now officially available in Malaysia, offering a new treatment option for adults living with obesity or who are overweight with related health issues. The launch comes as Malaysia grapples with a growing health crisis. The latest National Health […]